82 related articles for article (PubMed ID: 8627579)
21. Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans.
Walsh SL; Strain EC; Abreu ME; Bigelow GE
Psychopharmacology (Berl); 2001 Sep; 157(2):151-62. PubMed ID: 11594439
[TBL] [Abstract][Full Text] [Related]
22. kappa-Opioid receptor effects of butorphanol in rhesus monkeys.
Vivian JA; DeYoung MB; Sumpter TL; Traynor JR; Lewis JW; Woods JH
J Pharmacol Exp Ther; 1999 Jul; 290(1):259-65. PubMed ID: 10381785
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological characterization of an operant discrimination among two doses of morphine and saline in pigeons.
Vanecek SA; Young AM
Behav Pharmacol; 1995 Nov; 6(7):669-681. PubMed ID: 11224369
[TBL] [Abstract][Full Text] [Related]
24. Discriminative stimulus effects of nalbuphine in nontreated and morphine-treated pigeons.
Walker EA; Hawkins ER; Tiano MJ; Picker MJ; Dykstra LA
Pharmacol Biochem Behav; 1999 Oct; 64(2):445-8. PubMed ID: 10515328
[TBL] [Abstract][Full Text] [Related]
25. Naloxone benzylhydrazone is a µ-selective opioid antagonist without kappa agonist effects in rhesus monkeys.
France CP; Woods JH
Behav Pharmacol; 1992 Apr; 3(2):133-141. PubMed ID: 11224111
[TBL] [Abstract][Full Text] [Related]
26. Discriminative stimulus effects of two doses of fentanyl in rats: pharmacological selectivity and effect of training dose on agonist and antagonist effects of mu opioids.
Zhang L; Walker EA; Sutherland J; Young AM
Psychopharmacology (Berl); 2000 Feb; 148(2):136-45. PubMed ID: 10663428
[TBL] [Abstract][Full Text] [Related]
27. Kappa agonist-induced reinstatement of cocaine seeking in squirrel monkeys: a role for opioid and stress-related mechanisms.
Valdez GR; Platt DM; Rowlett JK; Rüedi-Bettschen D; Spealman RD
J Pharmacol Exp Ther; 2007 Nov; 323(2):525-33. PubMed ID: 17702903
[TBL] [Abstract][Full Text] [Related]
28. Further characterization of the discriminative stimulus effects of spiradoline.
Holtzman SG
Pharmacol Biochem Behav; 2000 Jul; 66(3):517-22. PubMed ID: 10899364
[TBL] [Abstract][Full Text] [Related]
29. Opioids and rate of positively reinforced behavior: differential antagonism by naltrexone.
Pitts RC; West JP; Morgan D; Dykstra LA; Picker MJ
Behav Pharmacol; 1996 May; 7(3):205-215. PubMed ID: 11224413
[TBL] [Abstract][Full Text] [Related]
30. Assessment of opioid partial agonist activity with a three-choice hydromorphone dose-discrimination procedure.
Jones HE; Bigelow GE; Preston KL
J Pharmacol Exp Ther; 1999 Jun; 289(3):1350-61. PubMed ID: 10336526
[TBL] [Abstract][Full Text] [Related]
31. Serotonin involvement in the discriminative stimulus effects of mu and kappa opioids in rats.
Powell KR; Picker MJ; Dykstra LA
Behav Pharmacol; 1994 Jun; 5(3):255-264. PubMed ID: 11224275
[TBL] [Abstract][Full Text] [Related]
32. Sex and rat strain determine sensitivity to kappa opioid-induced antinociception.
Barrett AC; Cook CD; Terner JM; Roach EL; Syvanthong C; Picker MJ
Psychopharmacology (Berl); 2002 Mar; 160(2):170-81. PubMed ID: 11875635
[TBL] [Abstract][Full Text] [Related]
33. Discriminative stimulus effects of intravenous heroin and its metabolites in rhesus monkeys: opioid and dopaminergic mechanisms.
Platt DM; Rowlett JK; Spealman RD
J Pharmacol Exp Ther; 2001 Nov; 299(2):760-7. PubMed ID: 11602692
[TBL] [Abstract][Full Text] [Related]
34. Chronic l-alpha acetylmethadol in rhesus monkeys: discriminative stimulus and other behavioral measures of dependence and withdrawal.
Brandt MR; France CP
J Pharmacol Exp Ther; 1998 Dec; 287(3):1029-37. PubMed ID: 9864289
[TBL] [Abstract][Full Text] [Related]
35. Relative efficacy of buprenorphine, nalbuphine and morphine in opioid-treated rhesus monkeys discriminating naltrexone.
Sell SL; McMahon LR; France CP
J Pharmacol Exp Ther; 2003 Sep; 306(3):1167-73. PubMed ID: 12766254
[TBL] [Abstract][Full Text] [Related]
36. Agonist/antagonist properties of nalbuphine, butorphanol and (-)-pentazocine in male vs. female rats.
Craft RM; McNiel DM
Pharmacol Biochem Behav; 2003 Apr; 75(1):235-45. PubMed ID: 12759132
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the discriminative and neuroendocrine effects of centrally penetrating kappa-opioid agonists in rhesus monkeys.
Butelman ER; Ball JW; Kreek MJ
Psychopharmacology (Berl); 2002 Oct; 164(1):115-20. PubMed ID: 12373425
[TBL] [Abstract][Full Text] [Related]
38. Interactions between kappa opioid agonists and cocaine. Preclinical studies.
Mello NK; Negus SS
Ann N Y Acad Sci; 2000; 909():104-32. PubMed ID: 10911926
[TBL] [Abstract][Full Text] [Related]
39. The discriminative stimulus effects of morphine in pigeons responding under a progressive ratio schedule of food presentation.
Brandt MR; Galici R; France CP
Behav Pharmacol; 2000 Feb; 11(1):15-28. PubMed ID: 10821205
[TBL] [Abstract][Full Text] [Related]
40. The adrenergic receptor agonist, clonidine, potentiates the anti-parkinsonian action of the selective kappa-opioid receptor agonist, enadoline, in the monoamine-depleted rat.
Hill MP; Brotchie JM
Br J Pharmacol; 1999 Dec; 128(7):1577-85. PubMed ID: 10602339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
